11 rezultatus
TECHNICAL FIELD OF THE INVENTION
This invention relates to the field of substances which have anti-inflammatory or anti-tumor activity and to diagnostic testing of patients for regulation of tumor necrosis factor and elastase activity.
BACKGROUND OF THE INVENTION
Tumor necrosis factor (TNF) is an
INCORPORATION BY REFERENCE
All publications and patent applications mentioned in this specification are herein incorporated by reference in their entirety to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by
INCORPORATION BY REFERENCE
All publications and patent applications mentioned in this specification are herein incorporated by reference in their entirety to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by
BACKGROUND OF THE INVENTION
The invention relates to anti-thiol reagents which inhibit enzyme activity of cell-associated protein disulfide isomerase (PDI) by oxidizing or blocking PDI active site vicinal thiol groups which normally participate in disulfide bond rearrangement of PDI substrates.
BACKGROUND OF THE INVENTION
The invention relates to anti-thiol reagents which inhibit enzyme activity of cell-associated protein disulfide isomerase (PDI) by oxidizing or blocking PDI active site vicinal thiol groups which normally participate in disulfide bond rearrangement of PDI substrates.
FIELD OF THE INVENTION
The present invention relates to dihydropyridine derivatives and salts thereof More particularly, the present invention relates to dihydropyridine derivatives and salts thereof, process for preparing the same, as well as pharmaceutical composition containing the same as the
FIELD OF THE INVENTION
The present invention relates to dihydropyridine derivatives and salts thereof. More particularly, the present invention relates to dihydropyridine derivatives and salts thereof, process for preparing the same, as well as pharmaceutical composition containing the same as the
1. FIELD OF THE INVENTION
The present invention relates to compositions and methods for the treatment of various neurological diseases and neurodegenerative disorders, particularly those affected by an overabundance of Amyloid Precursor Protein (APP). In particular, it has been discovered that APP
1. FIELD OF THE INVENTION
The present invention relates to compositions and methods for the treatment of various neurological diseases and neurodegenerative disorders, particularly those affected by an overabundance of Amyloid Precursor Protein (APP). In particular, it has been discovered that APP
FIELD OF THE INVENTION
The present invention relates to compositions and methods for the treatment of various neurological diseases and neurodegenerative disorders, particularly those affected by an overabundance of Amyloid Precursor Protein (APP). In particular, it has been discovered that APP
1. FIELD OF THE INVENTION
The present invention relates to compositions and methods for the treatment of various neurological diseases and neurodegenerative disorders, particularly those affected by an overabundance of Amyloid Precursor Protein (APP). In particular, it has been discovered that APP